The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.smaller Cos. Regulatory News (BSV)

Share Price Information for Br.smaller Cos. (BSV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 80.00
Bid: 78.50
Ask: 81.50
Change: 0.00 (0.00%)
Spread: 3.00 (3.822%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 80.00
BSV Live PriceLast checked at -
British Smaller Companies VCT is an Investment Trust

To maximise Total Return and provide investors with an attractive long-term tax-free dividend yield while maintaining the Company's status as a venture capital trust.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Allotment of Shares and Adjustment to Offer Price

23 Mar 2011 07:00

RNS Number : 4383D
British Smaller Companies VCT PLC
23 March 2011
 



BRITISH SMALLER COMPANIES VCT PLC

ALLOTMENT OF SHARES AND ADJUSTMENT TO OFFER PRICE FOR SHARES UNDER THE JOINT OFFERS FOR SUBSCRIPTION

 

British Smaller Companies VCT plc ("the Company") and British Smaller Companies VCT2 plc ("BSC2") are seeking to raise up to £15 million, in aggregate, by way of offers for subscription of up to 8,780,488 ordinary shares in the Company and of up to 12,811,388 ordinary shares in BSC2 ("Offers for Subscription"). Full details of the Offers for Subscription are contained in a prospectus issued by the Companies on 8 December 2010 ("Prospectus").

The Company announces that on 22 March 2011 it allotted 2,025,838 ordinary shares of 10 pence each ("Ordinary Shares") at a price of 128 pence per Ordinary Share in respect of valid subscriptions received for the tax year 2010/2011 pursuant to the Offers for Subscription. Of the Ordinary Shares allotted, 6,137 were allotted to Helen Sinclair and 1,972 were allotted to Edward Buchan (being directors of the Company), their having submitted their applications for subscription prior to 28 February 2011.

The directors of the Company further announce that the unaudited net asset value of the Company with effect from 28 February 2011 was 120.9 per Ordinary Share increased from 96.8 pence per Ordinary Share as set out in the Prospectus representing an increase of 24.9%. This increase in the unaudited net asset value of the Company has arisen as a result of two new portfolio considerations; a revision of the aggregate portfolio valuation and a revision of an individual portfolio valuation following indicative offers to acquire some or all of the Company's investment by external parties.

These approaches have valued the portfolio company using a different valuation methodology to the one historically used in the Company's accounts. The board of the Company has decided to adopt this valuation methodology and this has increased the valuation of the investment which in turn has increased the Company's unaudited net asset value. The new valuation does not fully reflect the value that might be achieved if one of these approaches leads to a completed transaction and there can be no certainty that this will be the outcome.

In addition, there is a revision of the aggregate portfolio valuation of the Company as a result of updating the valuations of the quoted and unquoted portfolio as of 28 February 2011.

In consequence the Offer Price (as defined in the Prospectus) was adjusted on 22 March 2011 in accordance with the Pricing Mechanism described in the Prospectus to take account of the increased unaudited net asset value of the Company as at the last day of the month preceding the allotment on 22 March 2011. Accordingly, the Ordinary Shares allotted by the Company on 22 March 2011 were, and (subject to no further adjustments to the net asset value of the Company) all further allotments of Ordinary Shares by the Company pursuant to the Offers for Subscription will be, allotted at 128 pence per Ordinary Share, being the unaudited net asset value as at 28 February 2011 plus 5.5% of gross proceeds (rounded to the nearest 0.25 pence per share).

Application is now being made for the Ordinary Shares which were allotted on 22 March 2011 to be admitted to the premium segment of the Official List of the UK Listing Authority and to trading on the London Stock Exchange's main market for listed securities, and dealings are expected to commence on or around 29 March 2011.

Following the allotment of the Ordinary Shares on 22 March 2011 the Company's issued share capital consists of 34,600,480 Ordinary Shares with voting rights ("Voting Capital") and 1,861,285 shares held in Treasury.

The above statement of Voting Capital may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FSA's Disclosure and Transparency Rules.

A further allotment of Ordinary Shares will be made by the Company on 5 April 2011 in respect of valid subscriptions for the tax year 2010/2011 received and accepted by the Company after 11.00 am on 22 March 2011 and before the close of the Offers in respect of the tax year 2010/2011 at 11.00am on 5 April 2011.

An allotment of Ordinary Shares will be made by the Company on 4 May 2011 in respect of valid subscriptions for the tax year 2011/2012 received and accepted by the Company before 11.00am on 4 May 2011.

For further information, please contact:

David Hall YFM Private Equity Limited Tel: 0113 294 5039

Jeff Keating Singer Capital Markets Tel: 0203 205 7500

 

 

END

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEEANDAAELFEFF
Date   Source Headline
3rd Apr 20247:58 amRNSIssue of Equity and Close of Offers
26th Mar 202411:11 amRNSTransaction in Own Shares and Total Voting Rights
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
15th Mar 202412:15 pmRNS3rd Quarter Results
16th Feb 20243:52 pmRNSClose of Offers to New Applications
16th Feb 20243:51 pmRNSClose of Offers to New Applications
30th Jan 20249:23 amRNSIssue of Equity
18th Dec 20234:02 pmRNSTransaction in Own Shares
13th Dec 20234:00 pmRNSOffer Update
13th Dec 20234:00 pmRNSStrategy/Company/Ops Update
8th Dec 20239:47 amRNSPayment of Dividend and Issue of Equity
24th Nov 20237:00 amRNSHalf-year Report
26th Oct 20231:34 pmRNSDividend Declaration
24th Oct 20231:20 pmRNSOffer Update
24th Oct 20231:19 pmRNSOffer Update
6th Oct 202310:19 amRNSOffer Update
6th Oct 202310:17 amRNSOffer Update
27th Sep 20238:21 amRNSOffer Update
26th Sep 20238:20 amRNSTransaction in Own Shares and PDMR
20th Sep 202312:30 pmRNSPublication of a Prospectus
20th Sep 202312:30 pmRNSPublication of a Prospectus
14th Sep 202310:28 amRNSResult of AGM
14th Sep 202310:28 amRNSResult of General Meeting
13th Sep 20237:00 amRNS1st Quarter Results
2nd Aug 202310:25 amRNSNew combined offer for subscription
2nd Aug 202310:25 amRNSNew combined offer for subscription
28th Jul 202310:00 amRNSDirector/PDMR Shareholding
28th Jul 202310:00 amRNSPayment of Dividend and Issue of Equity
27th Jun 20237:45 amRNSTransaction in Own Shares
21st Jun 20231:00 pmRNSPublication of Circular
16th Jun 202312:00 pmRNSAnnual Financial Report
4th Apr 20233:24 pmRNSDirector/PDMR Shareholding
4th Apr 20233:23 pmRNSIssue of Equity and Close of Offers
29th Mar 20238:42 amRNSTransaction in Own Shares
27th Mar 20236:00 pmRNSClose of Offers to new Applications
27th Mar 20236:00 pmRNSClose of Offers to new Applications
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
20th Mar 20233:00 pmRNS3rd Quarter Results
14th Feb 20234:35 pmRNSOffer Update
14th Feb 20234:35 pmRNSOffer Update
11th Jan 202310:00 amRNSDirector/PDMR Shareholding
11th Jan 202310:00 amRNSPayment of Dividend and Issue of Equity
19th Dec 20228:48 amRNSTransaction in Own Shares
6th Dec 20229:58 amRNSOffer Update
6th Dec 20229:58 amRNSOffer Update
30th Nov 202212:30 pmRNSPublication of a Prospectus
30th Nov 202212:30 pmRNSPublication of a Prospectus
25th Nov 20229:30 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.